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Objective: Biochemical host defenses at mucosal sites, such as the oral cavity, play a key role in the regulation of
microbial ecology and the prevention of infectious disease. These biochemical factors have distinct features, some
of which benefit the host and some that benefit bacteria. We investigated the effects of acute stress on the salivary
levels of the carbohydrate structure sulfo-Lewisa (sulfo-Lea), which is linked to the mucosal glycoprotein MUC5B.
Sulfo-Lea was recently identified as an adhesion molecule for Helicobacter pylori; therefore, we also measured
saliva-mediated adherence (ex vivo) of H. pylori. The oral cavity is suspected to be involved in the transmission of
H. pylori. Methods: Saliva was collected from 17 undergraduates before (baseline), during (stress), and after
(recovery) exposure to a video showing surgical procedures. In addition, blood pressure, an impedance cardiogram,
and an electrocardiogram were recorded. Results: During stressor exposure, participants reported increased state
anxiety. In addition, stroke volume increased and heart rate decreased. The stressor induced a strong increase in
salivary sulfo-Lea concentration (U/ml), sulfo-Lea output (U/min), sulfo-Lea/total protein ratio (U/mg protein), and
saliva-mediated adherence (ex vivo) of H. pylori. As expected, sulfo-Lea concentration correlated with the adher-
ence of H. pylori (r 5 0.72, p , .05). It was demonstrated that the observed adherence was induced by MUC5B and
that the carbohydrate structure sulfo-Lea contributed to this process. Conclusions: Our study demonstrated a direct
link between stress-mediated biochemical changes and altered host-microbe interactions in humans. Increased
bacterial adherence may be a contributing factor in the observed relationship between stress and susceptibility to
infectious disease. Key words: sulfo-mucin, MG1, psychoneuroimmunology, innate immunity, laboratory stress,
microbiology.
DBP 5 diastolic blood pressure; ECG 5 electrocardio-
gram; ELISA 5 enzyme-linked immunosorbent assay;
HR 5 heart rate; ICG 5 impedance cardiogram;
MANOVA 5 multivariate analysis of variance; PBS 5
phosphate-buffered saline; PEP 5 preinjection period;
RSA 5 respiratory sinus arrhythmia; SBP 5 systolic
blood pressure; S-IgA 5 secretory immunoglobulin A;
sulfo-Lea 5 sulfo-Lewisa; SV 5 stroke volume; U 5
ELISA units.
INTRODUCTION
For many years, investigators have documented the
impact of behavioral factors on immune functioning as
a possible determinant of the observed relationship
between stress and susceptibility to infectious disease
(1, 2). Infections are often initiated at mucosal sur-
faces, which form a boundary with the outside world.
Host defense at mucosal surfaces is mediated by both
nonspecific and immunologically specific mecha-
nisms (3–5). Several studies in psychoimmunology
have utilized S-IgA as an index of specific mucosal
immune function (6). However, the effects of behav-
ioral factors on nonspecific mucosal defenses remain,
with a few exceptions (7–9), unexplored.
Nonspecific mucosal defense is established by a
multitude of proteins, most of which are not produced
by cells of the immune system but by secretory gland
cells (4, 10). These secretory proteins protect the body
against invading bacteria, viruses, yeasts, and toxins,
by means of many biochemically different mecha-
nisms. Examples of such antimicrobial mechanisms
are killing, growth inhibition, inactivation of proteo-
lytic enzymes, and prevention of adherence to host
tissue (11–16). In this regard, the adjective “nonspecif-
ic” is a misnomer, considering the enormous func-
tional diversity and specificity of this heterogeneous
population of proteins.
The study described here addressed “nonspecific”
host defense in saliva. Saliva plays a crucial role in the
maintenance of oral health, which becomes dramati-
cally clear in patients with xerostomia, or dry mouth
syndrome. One of the symptoms of this syndrome is a
rapid increase in dental caries and other oral infec-
tions, accompanied by an increase in pathogenic bac-
teria (17). However, the functions of saliva are not
limited to the protection of the oral cavity because the
mouth also serves as a reservoir and portal of entry for
microorganisms that are active elsewhere in the body.
These include several Streptococcus species (18), He-
mophilus influenzae (19), Epstein-Barr virus, and her-
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pes simplex virus (20). Here, the role of saliva is not
necessarily a protective one. For example, whereas
HIV is inactivated by saliva (21), pathogens such as
Epstein-Barr virus and herpes simplex virus are, in
fact, transmitted by saliva (20). It is for this reason that
the pathological condition that results from Epstein-
Barr virus infection is nicknamed “the kissing dis-
ease.”
Because the mouth functions as the portal of entry
to the gastrointestinal system, the possible role of the
oral cavity in the transmission of Helicobacter pylori
has been debated in recent years (22–24). H. pylori
plays a causative role in the pathogenesis of gastritis,
gastric atrophy, and peptic and duodenal ulcers
(25, 26). Infection with this bacterium is also associ-
ated with an increased risk of gastric adenocarcinoma
and the occurrence of mucosa-associated lymphoid
tissue lymphoma (27, 28). Consequently, H. pylori is
classified as a type I human carcinogen (29). Although
the human stomach is the only well-established “res-
ervoir” of H. pylori, in patients suffering from gastric
infections, the microorganism has been detected at
various sites of the oral cavity, such as the palate,
cheeks, gingival pockets, dental plaque, and saliva
(30–36). Therefore, the oral-oral route has been sug-
gested as a modality of transmission for this infection.
Although the debate on the oral-oral transmission of H.
pylori is as yet undecided, alternative modalities of
transmission (eg, fecal-oral and gastric-oral) also in-
volve the oral cavity (22, 25, 37, 38). In addition, it has
been suggested that the oral cavity is a possible source
of reinfection in cases where H. pylori has been erad-
icated from the stomach (32, 39).
The carbohydrate structures that are linked to gly-
coproteins often function as attachment sites for bac-
teria and viruses (40, 41). Recently, the carbohydrate
structure sulfo-Lea was identified as an adhesion mol-
ecule for H. pylori (42, 43). In saliva, sulfo-Lea is
uniquely present on the glycoprotein MUC5B1, termi-
nating the carbohydrate chains linked to this glycop-
rotein (10). MUC5B, secreted by the sublingual, sub-
mandibular, and palatine salivary glands, is a very
large mucosal glycoprotein, or mucin, present in a
mucous protein layer that covers and protects the tis-
sues of the oral cavity (44, 45). As a main constituent of
this mucous layer, MUC5B is a potential site of attach-
ment for organisms that colonize the oral cavity.
MUC5B is also present in the secretions of the respi-
ratory tract, eyes, and gastrointestinal tract (10). Al-
though the exact physiological significance of the at-
tachment of H. pylori to salivary MUC5B is still
unclear, possible functions may be facilitation of trans-
port to the stomach or colonization of the oral epithe-
lium.
Aim of Study
There exists convincing evidence of links between
stress and susceptibility to infectious disease in hu-
mans, and much research in behavioral medicine is
dedicated to specifying the exact physiological path-
ways responsible for this link. However, most research
in this field is concentrated on humoral and cellular
immunity and almost completely ignores the possible
role of innate biochemical defenses. In this study, we
investigated the effects of acute stress on the secretion
in saliva of the carbohydrate structure sulfo-Lea, which
is linked to the glycoprotein MUC5B. In addition, we
quantified the saliva-mediated adherence (ex vivo) of
H. pylori. Adhesion is a process by which microbes
gain a stable foothold at the portal of entry. Microbial
adhesion forms a first and essential step in the course
of an infection (46). The primary aim of this study was
to establish whether stress-mediated biochemical al-
terations in mucosal secretions (salivary levels of
sulfo-Lea) could be linked directly to an altered host-
microbe interaction (saliva-mediated adherence of H.
pylori).
MATERIALS AND METHODS
Participants and Procedure
Study participants were 18 male undergraduate volunteers rang-
ing in age from 18 to 29 years (mean, 23 years). Participants received
15 Dutch guilders for their participation. None of the students were
on medication, and all stated that they were in good health. Partic-
ipants were instructed to abstain from smoking, drinking caffeine-
containing beverages, and engaging in physical exercise for 1 hour
before the experiment. All participants gave written informed con-
sent on the aim and procedure of the study.
Measurements were recorded between 1:30 and 4:00 PM. On
arrival, the experimental procedure was explained to the subject,
electrodes for electrocardiography and impedance cardiography
were attached, and the method of saliva collection was rehearsed.
Participants then filled out a self-report questionnaire and were
allowed to read self-selected magazines with neutral content for 20
minutes. The experiment started with a baseline measurement last-
ing 8 minutes. The experimental manipulation in this study was an
11-minute video showing bloody dental procedures, such as the
extraction of front teeth and removal of a molar with a pick. This
video was selected from among several videos on the basis of results
of a separate pilot study (N 5 20). Pilot study participants typically
characterized the selected video as “horrible” or “gruesome” and
reported increased anxiety during viewing.
Saliva was collected before the video was shown (baseline),
during the final part of the video (stressor), and 10 minutes after the
end of the video (recovery). Immediately after each saliva collection,
1 Note added at proofs: In this paper, the term MUC5B denotes the
whole high-molecular weight salivary mucin fraction, for which the
term MG1 is in use also. This high-molecular weight mucin fraction
may contain some other mucin gene products besides MUC5B.
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participants also filled out a state anxiety questionnaire. The ECG
and ICG were recorded continuously.
Saliva Collection
The method of saliva collection was practiced before the start of
the experiment to ensure standardization. Saliva was collected by
means of the spitting method according to the directions given by
Navazesh (47). This method was shown to have adequate retest
reliability (r 5 0.79), which was confirmed by our data. The collec-
tion trial starts with the instruction to void the mouth of saliva by
swallowing. Subsequently, saliva is allowed to accumulate in the
floor of the mouth without stimulation of saliva secretion by means
of orofacial movements (unstimulated saliva). The participant spits
into a preweighed, ice-chilled test tube every 60 seconds. Each
saliva collection period was 4 minutes. After collection, saliva was
homogenized by vigorous shaking using a vortex and clarified by
centrifugation (10,000g, 5 minutes) to eliminate buccal cells and oral
microorganisms. The clear supernatant was divided into 500-ml
aliquots and stored at 220°C until use.
Materials
Monoclonal antibody against sulfo-Lea was prepared in our lab-
oratory as described by Veerman et al. (48, 49). A panel of polyclonal
sera against H. pylori was kindly provided by Ben J. Appelmelk and
Theo Verboom (Department of Medical Microbiology, Vrije Univer-
siteit, Amsterdam). Details on the production of these antisera are
described by Appelmelk et al. (50). The polyclonal antiserum used
in this study was selected after testing a panel of anti-H. pylori
polyclonal antisera for cross-reactivity with saliva. H. pylori strain
NCTC 11637 was obtained from the National Collection of Type
Cultures (Public Health Laboratory Service, London, UK). Bicincho-
ninic acid (BCA) protein assay reagent was obtained from Pierce
(Rockford, UK), and microtiter plates were from Greiner (Reckling-
hausen, Germany) and Dynex (Chantilly, VA). Polymeric neoglyco-
conjugates for the blocking assay were obtained from Synstone (Mu-
nich, Germany). All other chemicals were obtained from Sigma
Chemical Company (St. Louis, MO). Blood pressure was measured
with a Dinamap Vital Signs Monitor (model 845 XT, Critikon,
Tampa, FL). ICG and ECG signals were recorded using six Ag/AgCl
spot electrodes (AMI type 1650–005, Medtronic, Haverhill, MA)
and the Vrije Universiteit Ambulatory Monitoring Device (Amster-
dam, The Netherlands) (51).
Cardiovascular Assessment
Assessment of cardiovascular response focused on blood pres-
sure and cardiac autonomic balance. SBP and DBP were measured
every 2 minutes during each of the three separate conditions. Indices
of sympathetic and parasympathetic drive were obtained by analysis
of the ECG and thoracic impedance (ICG) signals (52, 53). The ECG
and ICG complexes were ensemble-averaged with reference to the
ECG R wave across 1-minute periods (54). From these ensembles,
condition averages were extracted for interbeat interval, PEP, SV,
and left ventricular ejection time. Spectral power of HR was derived
by frequency domain analysis of the continuously recorded inter-
beat interval time series using the CARSPAN program (55). Two
frequency bands were deemed of interest in the integrated power
density spectra: the frequency band around the intrinsic blood pres-
sure oscillations (0.07–0.14, BLOOD) and the high-frequency band
(0.15–0.40) that reflects RSA. In the time domain, the root mean
square of successive differences was used as an alternative index of
RSA. Changes in PEP and BLOOD have been used to index changes
in cardiac sympathetic drive (56, 57), whereas changes in RSA and
root mean square of successive differences are used to index changes
in cardiac vagal tone.
Determination of MUC5B-Linked Sulfo-Lea and
Total Salivary Protein
For the quantification of sulfo-Lea, an ELISA was used as de-
scribed in detail by Veerman et al. (48). Protein was measured by the
bicinchoninic acid method (58). This assay is described in detail by
Bosch et al. (7). All assays have a split-half reliability of .0.98.
Bacteria
A strain of H. pylori NCTC 11637 (also designated ATCC 34504,
American Type Culture Collection, Manassas, VA) was grown for 4
days under microaerophilic conditions (10% CO2, 5% O2, 85% N2)
at 37°C on Dent agar plates (59) supplemented with 2,3,5-triphenyl-
tetrazolium chloride (40 mg/ml). Cultures were harvested by cen-
trifugation (4000g, 4°C), washed in sodium acetate buffer (100 mM,
pH 5.0), and resuspended in sodium acetate buffer (with 0.5%
Tween-20 added) to an optical density of 0.1 at 700 nm.
Adherence Assay
Adherence of H. pylori was measured by means of an ELISA. In
96-well microtiter plates (Immulon 1B, medium affinity), 100 ml of
saliva was threefold serially diluted in 0.1 M NaHCO3 buffer (pH 9.6)
with a starting solution of 1:400. Microtiter plates were subsequently
incubated for 3 hours at 37°C. After incubation, the wells were
rinsed three times with PBS (50 mM potassium phosphate, 0.15 M
sodium chloride, pH 7.4) containing 0.1% (v/v) Tween-20, followed
by two rinses with demineralized water. This rinsing was done
between each incubation step. Then, 100 ml of a freshly prepared
bacterial suspension was added. After incubation (1 hour, 37°C) and
subsequent washing, 100 ml of rabbit-anti-H. pylori polyclonal anti-
body (diluted 1:500 in PBS with 0.1% Tween-20 plus 3% bovine
serum albumin) was added. After 1 hour of incubation and subse-
quent washing, horseradish peroxidase–conjugated goat anti-rabbit
immunoglobulin (100 ml, diluted 1:6000 in PBS with 0.1%
Tween-20 plus 3% bovine serum albumin) was added. After incu-
bation (1 hour, 37°C), the microtiter wells were again rinsed, and 90
ml of the substrate-containing solution was added (1,19 orthophe-
nylene diamine, 0.03% H2O2 in 50 mM citrate, 0.1 M disodium
phosphate, pH 5.0). Color was allowed to develop until sufficient
intensity was reached. The reaction was stopped by adding 50 ml of
a 4M H2SO4 solution, and absorbance was measured at 492 nm using
a microtiter plate reader (Dynatech MR 7000). Adherence of H.
pylori was quantified by calibration against the dose-response curve
obtained in the same assay of a pooled saliva sample. The level of
adherence of this pooled sample was indexed on 100. The assay was
performed in triplicate, and the average was used. The intraassay
variability of the assay is 8.1%.
Purification of MUC5B
MUC5B was isolated from saliva by ultracentrifugation
(100,000g, 24 hours) under dissociative conditions, followed by gel
filtration (Sephacryl HR-500, Pharmacia, Uppsala, Sweden) in 50
mM Tris/HCl/4 M guanidine chloride, pH 7.4 (60). The mucin-
containing fractions were pooled, dialyzed against double-distilled
water, and stored as aliquots at 220°C.
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Inhibition Assays
To test whether the adherence in our assay was mediated by
MUC5B, purified MUC5B was added to the H. pylori suspension and
incubated for 1 hour at 37°C. The suspensions contained three
concentrations of MUC5B: 100, 400, and 1600 mg/ml. A bacterial
suspension without MUC5B was used as a control. Subsequently,
adherence assays were performed.
In a second experiment, the bacterial suspension was incubated
with an excess (30 mg/ml) of synthetic sulfo-3-galactose, the terminal
part of sulfo-Lea, bound to a polyacrylamide carrier (61). This syn-
thetic oligosaccharide is known to compete with MUC5B for binding
to H. pylori by occupying an adhesion molecule (designated neutro-
phil-activating protein) that specifically binds to sulfated carbohy-
drate (43). The bacterial suspension was incubated for 1 hour at
37°C. Subsequently, adherence assays were performed. Controls in-
volved adherence of H. pylori after preincubation with buffer and
with a nonrelevant carbohydrate-polyacrylamide conjugate (b-galac-
tose-polyacrylamide).
Questionnaires
Participants were administered the Dutch translation of the
Spielberger State/Trait-Anxiety Inventory (62). The state anxiety
part (20 items) of this questionnaire was administered immediately
after each saliva collection. The instruction after the second saliva
collection was adapted to report on the anxiety the subject felt while
viewing the video.
Participants also filled out a self-report questionnaire on health
(perceived health and use of medication or other medical treatment),
life habits, and behavior on the day of the experiment (smoking,
alcohol, tea and coffee consumption, physical exercise, and sleep
duration and quality).
Data Analysis
Data were analyzed with MANOVA (SPSSWIN7.5) using the
three conditions (baseline, film, recovery) as within-subject factors.
Because of their skewed distribution, salivary parameters and spec-
tral data were logarithmically transformed before statistical analy-
ses. For readability, the original (untransformed) values are used in
the figures.
RESULTS
One participant terminated his participation in the
experiment because he feared fainting. The analyses
are confined to the remaining 17 subjects.
State Anxiety
Mean state anxiety increased from 11.8 (SEM 5 2.4)
at baseline to 19.3 (SEM 5 2.6) during the stressor
(t(16) 5 2.7, p 5 .01). After recovery, mean state anx-
iety returned to just below the baseline value (mean 5
9.9, SEM 5 2.1; t(16) 5 3.6, p 5 .002).
MUC5B-Linked Sulfo-Lea and Adherence of H.
pylori
Figure 1 shows the median, mean, and standard
error of salivary concentration (U/ml), output (U/min),
and total protein ratio (U/mg protein) of sulfo-Lea mea-
sured at baseline, during the stressor, and during re-
covery. Sulfo-Lea was quantified as ELISA units (U)
using a pooled saliva sample as a standard. A measure
of sulfo-Lea output (U/min) was computed to control
for salivary flow rate and is obtained by multiplying
concentration (U/ml) by flow rate (ml/min). The sulfo-
Lea/protein ratio was computed to obtain a measure of
specificity: An increased ratio indicates that sulfo-Lea
output occurs at a higher rate than the output of other
secretory proteins. Figure 2 shows the median, mean,
and standard error of saliva-mediated adherence of H.
pylori (ex vivo).
MANOVA indicated a significant effect of the ma-
nipulation on sulfo-Lea levels and adherence (F(8,9) 5
4.59, p 5 .018). Subsequent multivariate analyses
showed that baseline and stressor values differed sig-
nificantly (F(4,13) 5 9.68, p 5 .001) and that recovery
and stressor values also differed significantly
(F(4,13) 5 4.61, p 5 .015), whereas baseline and recov-
ery values did not differ significantly(F(4,13) 5 1.44,
p 5 .275).
Post hoc analysis, using paired t tests, indicated that
sulfo-Lea concentration differed both between baseline
and stressor (t(16) 5 3.73, p 5 .002) and between
stressor and recovery (t(16) 5 3.14, p 5 .006) (Figure
1). Sulfo-Lea output (U/ml) also showed an increase
during stressor exposure, as compared with both base-
line (t(16) 5 4.53, p , .001) and recovery (t(16) 5 3.69,
p 5 .002) (Figure 1), indicating that the observed in-
crease in sulfo-Lea concentration is not due to alter-
ations in flow rate. The sulfo-Lea/protein ratio showed
the same pattern as the two previous parameters: a
significant increase during the stressor, as compared
with both baseline (t(16) 5 2.90, p 5 .01) and recovery
Fig. 1. Values of sulfo-Lea concentration (U/ml), sulfo-Lea output
(U/min), and sulfo-Lea/total protein ratio (U/mg protein).
Values are expressed in ELISA units (U). Bars and error bars
indicate mean values and standard errors, respectively.
Horizontal lines indicate median values. For statistical
analysis, log-transformed values were used.
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(t(16) 5 2.47, p 5 .03) (Figure 1), indicating that the
observed increase in sulfo-Lea output is specific and
cannot be attributed to a nonspecifically increased
protein secretion during stress. Finally, saliva-medi-
ated adherence of H. pylori was significantly increased
during the stressor, as compared with both baseline
(t(16) 5 4.31, p 5 .001) and recovery (t(16) 5 4.05, p 5
.001) (Figure 2). Because of the relatively small sample
size and skewness of our data, analyses were repeated
using nonparametric tests (Wilcoxon and sign tests),
yielding virtually the same results, with most signifi-
cant p values well below the .01 criterion.
Salivary flow rate showed a nonsignificant increase
during stressor exposure (F(2,15) 5 1.50, p 5 .24).
Variations in sulfo-Lea at baseline and during the stres-
sor and recovery were consistently and significantly
correlated with variations in adherence of H. pylori
(with Spearman rank correlation coefficients between
0.62 and 0.84, .05 . p . .001). Variations in salivary
flow rate did not correlate with adherence of H. pylori
or sulfo-Lea (p . .2), indicating that the increased
adherence of H. pylori was not a concentration artifact
due to an altered salivary flow rate.
Inhibition Studies
To test whether the observed correlation between
sulfo-Lea and adherence of H. pylori underlies a causal
relationship, two additional assays were performed as
described in Materials and Methods. Preincubation of
H. pylori with purified MUC5B reduced adherence in
a dose-dependent manner, completely blocking adher-
ence at a level of 1600 mg MUC5B/ml suspension (Fig-
ure 3). This result indicates that MUC5B is responsible
for the observed adherence of H. pylori to the saliva-
coated microtiter plate.
Preincubation of the H. pylori suspension with ga-
lactose-3-sulfate resulted in an approximately 4-fold
decrease in adherence, as compared with the controls,
preincubation with buffer, or preincubation with ga-
lactose-polyacrylamide (not shown). However, adher-
ence was not blocked completely, indicating that be-
sides sulfated glycans, other domains on the MUC5B
molecule are involved in the binding to H. pylori.
Cardiovascular Response
Significant effects of condition emerged only for HR
(F(2,15) 5 4.40, p 5 .031) and SV (F(2,15) 5 6.38, p 5
.019). Post hoc analysis indicated that HR decreased
during the film in comparison with the baseline value,
whereas baseline and recovery HR did not differ. The
decrease in HR during the film was paralleled by an
increase in SV. No other effects of condition emerged.
Values of selected cardiovascular parameters are pre-
sented in Table 1.
DISCUSSION
To the best of our knowledge, this is the first study
that has succeeded in demonstrating a direct link be-
tween stress-mediated biochemical changes and al-
Fig. 2. Saliva-mediated adherence (ex vivo) of H. pylori. Bars and
error bars indicate mean values and standard errors, respec-
tively. Horizontal lines indicate median values. Adherence
is quantified as an index value based on a pooled saliva
sample as a standard, indexed on 100.
Fig. 3. Effects of preincubation of H. pylori suspension with 0, 100,
400, and 1600 mg/ml MUC5B. These results show that
preincubation of H. pylori reduces adherence in a dose-
dependent manner, indicating that the observed adherence
is MUC5B dependent. Adherence was quantified as an in-
dex value based on a pooled saliva sample as a standard.
J. A. BOSCH et al.
44 Psychosomatic Medicine 62:40–49 (2000)
tered host-microbe interactions in humans. Our results
show enhanced saliva-mediated adherence (ex vivo) of
H. pylori during an acute stressor. This increase was
shown to correlate with an increase in sulfo-Lea, a
carbohydrate structure linked to the mucous glycopro-
tein MUC5B. Subsequent experiments, aimed at iden-
tifying the biochemical factors involved, demonstrated
that MUC5B is responsible for the observed saliva-
mediated adherence and that the oligosaccharide ga-
lactose-3-sulfate (the terminal part of the carbohydrate
moiety of sulfo-Lea) largely contributes to this process.
These results are in agreement with those of recent
studies showing that sulfated oligosaccharides on
MUC5B function as adhesion molecules for H. pylori
(42, 43).
The findings of our study resemble the results of
animal studies investigating the effects of acute stres-
sors (ie, water immersion and restraint stress) on the
activity of secretory cells in the colon, stomach, and
nasopharynx (63–71). These studies demonstrated ro-
bust effects of acute stress on mucin release, synthesis,
and glycosylation (a process in which carbohydrate
structures on proteins are formed). The relatively acute
increase in the secretion of sulfo-Lea observed in our
study is most likely due to an increased release of
MUC5B, not to an altered synthesis or glycosylation of
MUC5B, because the time necessary for glycosylation
and intracellular transport far exceeds 10 minutes (72).
The release of salivary proteins is mainly governed
by the synergistic actions of both the sympathetic and
parasympathetic branches of the autonomic nervous
system (73, 74) and is also modulated by several neu-
ropeptides that are released in conjunction with the
conventional transmitters acetylcholine and noradren-
aline (75, 76). Therefore, stress-induced autonomic ac-
tivation is the most likely explanation for the observed
release of MUC5B. Surprisingly, no consistent associ-
ation was observed between our cardiovascular indi-
ces and salivary parameters. Possibly, cardiac vagal
and sympathetic drive do not properly reflect activity
in parasympathetic and sympathetic branches that in-
nervate the MUC5B-secreting salivary glands. Future
pharmacological blockade studies may elucidate the
neural mechanisms involved.
Most laboratory studies in psychoneuroimmunol-
ogy make use of stressors that require mental effort and
that are characterized by their potential to evoke a
classic fight-flight cardiovascular response pattern (eg,
mental arithmetic, Stroop task, and reaction tasks)
(77–84). This clearly being the dominant paradigm, it
may become overlooked that there is a body of litera-
ture showing that many stressful situations do not
necessarily elicit a substantial cardiovascular response
and may even be associated with a reduced HR (85–
89). What becomes clear from our study is that such
stressors are nevertheless capable of inducing robust
biochemical changes with a clear effect on immuno-
logical functioning.
The binding of H. pylori to salivary mucins may
play a role in the colonization of this pathogen through
the oral route. Moreover, several pathogenic bacteria
other than H. pylori bind to MUC5B and/or sulfo-Lea,
and our results may therefore be extrapolated to these
microorganisms. Examples are Escherichia coli (90),
Staphylococcus aureus (91), Candida albicans (92),
Bordetella pertussis (93), Hemophilus influenzae (94),
and Fusobacterium nucleatum (Groenink J, Veerman
ECI, Nieuw Amerongen AV. 1999, unpublished data).
The latter two pathogens, which are involved in op-
portunistic infections of the respiratory tract and in
periodontal disease (chronic infection of the tooth-
supporting tissues), respectively, are especially of in-
terest within the context of this study because there is
a growing body of research showing an association of
both pathologies with stress (2, 95).
Because the mouth is the habitat of many microor-
ganisms and is involved in the transmission of many
microorganisms, an increased adherence of MUC5B-
and/or sulfo-Lea-binding organisms could affect sus-
ceptibility in three different ways. First, an increased
opportunity for microorganisms to colonize the oral
epithelium may imply an increased risk of being in-
fected through the oral route. Second, the increased
adherence to the tissues of the oral cavity might, in
case of oral-oral contact with a carrier of the pathogen,
cause exposure of another host to a relatively larger
inoculating dose (the number of microorganisms trans-
mitted). Because the inoculation dose is a crucial fac-
tor determining whether an infection will proceed
(46), increased adherence may therefore imply a
greater risk of infecting others. Third, a specifically
increased release of MUC5B, as seen in our study,
might favor the colonization of bacteria that preferen-
tially bind to MUC5B and/or the carbohydrates linked
to this glycoprotein. Likewise, microorganisms that do
not bind MUC5B (among which are many streptococci
TABLE 1. Means and Standard Deviations of Selected
Cardiovascular Parameters
Baseline Stressor Recovery
HRate (bpm) 68.1 (10.4) 65.6 (9.8) 66.4 (9.2)
SV (cm3) 116.2 (33.2) 123.4 (36.1) 114.0 (33.4)
RSA (ms2) 2230 (2367) 2347 (2524) 2309 (2829)
BLOOD (ms2) 1875 (1271) 2043 (2168) 1735 (1267)
PEP (ms) 113.1 (23.8) 113.9 (25.6) 115.4 (25.9)
SBP (mm Hg) 115.3 (10.7) 114.6 (10.7) 113.2 (7.8)
DBP (mm Hg) 69.1 (6.7) 68.4 (10.2) 68.6 (8.9)
SALIVA-MEDIATED ADHERENCE OF H. PYLORI DURING ACUTE STRESS
45Psychosomatic Medicine 62:40–49 (2000)
and staphylococci) are likely to be relatively unaf-
fected by an increase in MUC5B (94, 96–98). Conse-
quently, stress-mediated release of MUC5B might af-
fect the microbial homeostasis of the mucosa; that is,
when stress induces biochemical changes that are fa-
vorable for some species but not necessarily for others,
these changes may lead to a microbial population shift
(99–101).
CONCLUDING REMARKS
Research on the effects of psychosocial factors on
mucosal defense has concentrated almost exclusively
on S-IgA, the predominant immunoglobulin in muco-
sal secretions (6). However, the fact that S-IgA defi-
ciency is the most common form of immunodeficiency
and that individuals deficient in S-IgA show only a
marginally increased susceptibility to infectious dis-
ease (5) indicates that S-IgA is not the only factor.
Instead, mucosal defense is brought about by the com-
bined activity of many proteins, which for the most
part are produced not by cells of the immune system
but by the secretory glandular cells. In our opinion, the
relevance of the current study lies in the fact that it
exemplifies how psychological factors, by altering the
secretion of such proteins, can affect host-microbe in-
teractions.
The mucosa, especially that of the oral cavity, is an
extremely complex environment in which an enor-
mous diversity in microorganisms and host factors
interact. Therefore, some caution is needed in extrap-
olating our results to the in vivo situation. Future
studies may extend the approach presented in our
current study by examining different aspects of host-
microbe interactions simultaneously. The present
study and other studies carried out by our group (7, 8)
indicate that the secretion of nonimmunological pro-
teins is altered in subjects under stress. Moreover, our
results show that these alterations directly affect the
way in which microorganisms are dealt with. We
therefore conclude that the inclusion of innate de-
fense-system parameters in studies in the field of be-
havioral medicine may contribute to our understand-
ing of the relationship between stress and
susceptibility to infectious disease.
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ANNOUNCEMENT
The 12th International Congress on Psychonephrology will be held in Yokohama, Japan, June 2 and
3, 2000. Deadline for submission is April 15, 2000. Contact: Norman B. Levy, MD, Dept of Psychiatry,
Coney Island Hospital, 2601 Ocean Parkway, Brooklyn, NY 11235; FAX: (718) 616-4371. For other
countries, contact: Shingo Takesawa, PhD, Suzuka Univ of Medical Science, 10001-1 Kishiokacho,
Suzuka City, Mie 5100293, Japan, FAX: 81-593-83-9666.
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